摘要
现行《药品注册管理办法》中有关进口药物的申报和审批中规定:临床试验获得批准后,申请人应当按照药物临床试验及有关要求进行试验。本文拟就进口治疗用生物制品临床试验相关问题,如国际多中心临床试验与注册临床试验之间的相互关系,提出探讨性的意见。
It is stated in the current regulations for drug registration that, once clinical trial application from a foreign vendor is approved, the research should be conducted as required in the provisions. This paper pres- ents preliminary comments on the relationship between international multi-center and registration clinical trials re- garding the therapeutic biologics.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2013年第13期1496-1499,共4页
Chinese Journal of New Drugs
关键词
国际多中心临床试验
进口注册临床试验
治疗用生物制品
international multi-center clinical trial
registration clinical trial
therapeutic biologics